Please turn JavaScript on
2minutemedicine icon

2minutemedicine

Subscribe to 2minutemedicine’s news feed.

Click on “Follow” and decide if you want to get news from 2minutemedicine via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to 2minutemedicine comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from 2minutemedicine which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: 2 Minute Medicine | Concise. Curated. Medical News.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.42 / day

Message History

1. The antithrombotic agents aspirin, clopidogrel, and rivaroxaban were non-inferior to metoprolol for responder rate in participants with patent foramen ovale and migraine. Evidence Rating Level: 1 (Excellent) Patent foramen ovale (PFO) has been associated with migraine and has been suggested to involve a microembolic mechanism. Antithrombotic treatment has been proposed for...


Read full story

1. Active surveillance was cost-effective over 5 years compared with standard surgery in patients with esophageal cancer and complete clinical response after neoadjuvant chemoradiotherapy. Evidence Rating Level: 1 (Excellent) Active surveillance for patients with esophageal cancer and a complete clinical response (CCR) after neoadjuvant chemoradiotherapy (nCRT) is noninferior...


Read full story

1. Intraarterial dexamethasone was associated with greater pain relief after uterine fibroid embolization compared with placebo.  Evidence Rating Level: 1 (Excellent) Uterine fibroid embolization (UFE) is a minimally invasive treatment for symptomatic uterine fibroids, which are most common tumor of the female reproductive tract. However, a major limitation of UFE is acute po...


Read full story

1. Hematologic inflammatory indices in emergency department patients with COVID-19 showed an age-dependent prognostic performance for 30-day mortality, with systemic immune-inflammation index showing good discriminatory performance in patients <65 years and poorer performance in patients >65 years. Evidence Rating Level: 2 (Good) Hematologic markers derived from the com...


Read full story

1. Younger age (<59.6 years) and systemic metastases (>1) were independent predictors of survival among patients with choroidal metastases. Evidence Rating Level: 2 (Good) Around 1–2% of all cancer patients develop intraocular metastases, with the choroid representing the primary site of metastatic involvement (90%). It is unclear how age and primary tumor type impact s...


Read full story